Diisopropylethylamine → (S)-5-({[6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carbonyl]-amino}-methyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester

HRID 402044노트

반응식

HRID 402044 반응식
[CH2:1]([C:5]1[N:10]=[N:9][C:8]([C:11]([OH:13])=O)=[CH:7][C:6]=1[C:14]1[CH:19]=[CH:18][C:17]([O:20][CH:21]2[CH2:26][CH2:25][CH2:24][CH2:23][CH2:22]2)=[CH:16][CH:15]=1)[CH2:2][CH2:3][CH3:4].CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[C:51]([O:55][C:56]([N:58]1[CH2:62][C@H:61]([CH2:63][NH2:64])[O:60][C:59]1([CH3:66])[CH3:65])=[O:57])([CH3:54])([CH3:53])[CH3:52].CCN(C(C)C)C(C)C>CN(C=O)C.CCOCC.O>[C:51]([O:55][C:56]([N:58]1[CH2:62][C@H:61]([CH2:63][NH:64][C:11]([C:8]2[N:9]=[N:10][C:5]([CH2:1][CH2:2][CH2:3][CH3:4])=[C:6]([C:14]3[CH:15]=[CH:16][C:17]([O:20][CH:21]4[CH2:22][CH2:23][CH2:24][CH2:25][CH2:26]4)=[CH:18][CH:19]=3)[CH:7]=2)=[O:13])[O:60][C:59]1([CH3:66])[CH3:65])=[O:57])([CH3:54])([CH3:53])[CH3:52]

참가 물질

8

반응물 4

HCID 81531DiisopropylethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 673720716-Butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carboxylic acidHCID 67373621(S)-5-aminomethyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester

생성물 1

HCID 67373730(S)-5-({[6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carbonyl]-amino}-methyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester

시약·촉매·용매 3

HCID 962Water용매HCID 3283Diethyl Ether용매HCID 6228Dimethylformamide용매

실험 절차

To a mixture of 6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carboxylic acid (Example 93, 0.34 mmol, 0.12 g), HBTU (0.34 mmol, 0.13 g) and (S)-5-aminomethyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester (0.34 mmol, 0.05 mL) in DMF was added DIEA (1.0 mmol, 0.17 mL). Upon completion of the reaction, the mixture was diluted with ether, and then poured into water. The resulting mixture was extracted, the organic layer was dried. The solvent was removed, and the resulting residue was chromatographed with 4:1 hexane/EtOAc to provide (S)-5-({[6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carbonyl]-amino}-methyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester was used as is in the next step. LCMS: m/z 566.9 [M+1].

후처리

  1. customUpon completion of the reaction
  2. extractionThe resulting mixture was extracted
  3. customthe organic layer was dried
  4. customThe solvent was removed
  5. customthe resulting residue was chromatographed with 4:1 hexane/EtOAc

출처 및 근거

ORD 기록
ord-8e89c4b93fb1442c85c51a12a89b4b63
출처 데이터셋
uspto-grants-2014_06
특허 번호
US08741900B2

반응 노트

불러오는 중…